Exposure to hazardous drugs in Healthcare: An issue that will not go away

Journal of Oncology Pharmacy Practice

Volumn 17, Issue 1, 2011, Pages 9-13

  Davis, Jill ^a   McLauchlan, Robert ^a   Connor, Thomas H ^b  

^a AUSTIN HEALTH   (Australia)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; FLUOROURACIL; GEMTUZUMAB OZOGAMICIN; RITUXIMAB; TRASTUZUMAB;

CLOSED SYSTEM DRUG TRANSFER DEVICE; HUMAN; MEDICAL PRACTICE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PHARMACEUTICS; PHARMACY; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; REVIEW;

ANTINEOPLASTIC AGENTS; DRUG COMPOUNDING; DRUG INDUSTRY; HEALTH PERSONNEL; HUMANS; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH;

EID: 79952379479     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078155210388462     Document Type: Review

References (11)

1. Sewell GJ Pharmaceutical issues: preparation and handling. J Oncol Pharm Pract 1995 ; 1 (Suppl 1). 6-12.
2. Lee SG, Tkaczuk M., Jankewicz G. and Ambados F. Surface contamination from cytotoxic chemotherapy following preparation and administration. J Pharm Pract Res 2007 ; 37: 271-276. (Pubitemid 351269352)
3. Siderov J., Kirsa S. and McLauchlan R. Surface contamination of cytotoxic chemotherapy preparation areas in Australian hospital pharmacy departments. J Pharm Pract Res 2009 ; 39: 117-121.
4. Siderov J., Kirsa S. and McLauchlan R. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device. J Oncol Pharm Pract 2010 ; 16: 19-25.
5. McDiarmid MA Chromosome 5 and 7 abnormalities in healthcare workers handling antineoplastic drugs. In: Proceedings of the XII ISOPP, Prague, May 2010.
6. NIOSH alert. Preventing occupational exposure to antineoplastic and other hazardous drugs in healthcare settings. DHHS (NIOSH) Publication No. 2004-165. Cincinnati: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, 2004.
7. International Society of Oncology Pharmacy Practitioners. ISOPP standards of practice. Safe handling of cytotoxics. J Oncol Pharm Pract 2007 ; 13 (Suppl): 1-81.
8. American Society of Health-System Pharmacists. ASHP guidelines on handling hazardous drugs. Am J Health Syst Pharm 2006 ; 63: 1172-1193.
9. Ledford A., Maliakal P., Rogers TL and Mackey M. Evaluation of two closed system transfer devices in an outpatient community cancer centre. Poster 144. In: American College of Clinical Pharmacy annual meeting, Orlando, FL, October 2009.
10. McLauchlan R. and Rocca J. Using a closed-system drug transfer device for the preparation of hazardous drugs - technical tips. In: Poster Presentation, Society of Hospital Pharmacists of Australia Federal Conference, Sydney, 2007.
11. Bos JD and Meinardi Mmhm. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000 ; 9: 165-169. (Pubitemid 30255378)